Evidence map›Paper›PMID 24247150›Full record

ArticleCell cycle (Georgetown, Tex.)2014

The heterogenic final cell cycle of chicken retinal Lim1 horizontal cells is not regulated by the DNA damage response pathway.

Shahrzad Shirazi Fard, Charlotta All-Ericsson, Finn Hallböök

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Heterogeneity in retinoblastoma: a tale of molecules and models.Clinical and translational medicine · 2017
    Review
  4. Review
  5. A regulatory sequence from theMolecular vision · 2016
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. To go or not to go?Cell cycle (Georgetown, Tex.) · 2015
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shahrzad Shirazi FardDepartment of Neuroscience; BMC Uppsala University; Uppsala, Sweden.
Charlotta All-EricssonSt Eriks Ögonsjukhus; Karolinska Institutet; Stockholm, Sweden.
Finn HallböökDepartment of Neuroscience; BMC Uppsala University; Uppsala, Sweden.
Uppsala University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells with aberrations in chromosomal ploidy are normally removed by apoptosis. However, aneuploid neurons have been shown to remain functional and active both in the cortex and in the retina. Lim1 horizontal progenitor cells in the chicken retina have a heterogenic final cell cycle, producing some cells that enter S-phase without proceeding into M-phase. The cells become heteroploid but do not undergo developmental cell death. This prompted us to investigate if the final cell cycle of these cells is under the regulation of an active DNA damage response. Our results show that the DNA damage response pathway, including γ-H2AX and Rad51 foci, is not triggered during any phase of the different final cell cycles of horizontal progenitor cells. However, chemically inducing DNA adducts or double-strand breaks in Lim1 horizontal progenitor cells activated the DNA damage response pathway, showing that the cells are capable of a functional response to DNA damage. Moreover, manipulation of the DNA damage response pathway during the final cell cycle using inhibitors of ATM/ATR, Chk1/2, and p38MAPK, neither induced apoptosis nor mitosis in the Lim1 horizontal progenitor cells. We conclude that the DNA damage response pathway is functional in the Lim1 horizontal progenitor cells, but that it is not directly involved in the regulation of the final cell cycle that gives rise to the heteroploid horizontal cell population.

Indexed as

Cell Cycle CheckpointsDNA Breaks, Double-StrandedAnimalsAntineoplastic AgentsApoptosisAtaxia Telangiectasia Mutated ProteinsChick EmbryoChickensCisplatinDNA-Activated Protein KinaseDNA AdductsHistonesLIM-Homeodomain ProteinsPhosphorylationRad51 RecombinaseRetinal Horizontal CellsAntineoplastic AgentsAtaxia Telangiectasia Mutated ProteinsCisplatinDNA-Activated Protein KinaseDNA AdductsHistonesLIM-Homeodomain ProteinsRad51 RecombinaseZinostatinapoptosisATM/ATRcell cycle regulationcisplatinDNA damage responseH2AXprogrammed cell deathRad51retina

Identifiers

PMID24247150
PMCPMC3956536
OpenAlexW1984555625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.